tm logo
MEDRX
Live/Registered
REGISTERED

on 19 Feb 2019

Last Applicant/ Owned by

Higashikagawa-shi

Kagawa

JP

769-2712

Serial Number

87718256 filed on 12th Dec 2017

Registration Number

5682322 registered on 19th Feb 2019

in the Supplemental Register

Correspondent Address

ELENORE NIU

KNOBBE, MARTENS, OLSON & BEAR, LLP

2040 MAIN ST 14TH FL

IRVINE, CA 92614

Filing Basis

1. intent to use

Disclaimer

NO DATA

MEDRX

Color is not claimed as a feature of the mark. Pharmaceutical preparations used for the continuous release of a wide variety of therapeutic agents, namely, drug delivery system preparations comprised of adhesive preparations and transdermal patches, all incorporating therapeutic agents The mark consists of the stylized wording "MEDRX" in which the letters "RX" appear in a solid circle.

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations used for the continuous release of a wide variety of therapeutic agents, namely, drug delivery system preparations comprised of adhesive preparations and transdermal patches, all incorporating therapeutic agents

Mark Details


Serial Number

No 87718256

Mark Type

No Service/Collective Mark

Attorney Docket Number

No MEDRX.012TFC

44D Filed

No

44D Current

No

44E filed

Yes

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.01.21 -

Circles that are totally or partially shaded

Description of Design Search

The mark consists of the stylized wording "MEDRX" in which the letters "RX" appear in a solid circle.

Legal History


Show more

Status DateAction Taken
19th Feb 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
19th Feb 2019REGISTERED-SUPPLEMENTAL REGISTER
11th Jan 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
10th Jan 2019APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
29th Oct 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
29th Oct 2018TEAS/EMAIL CORRESPONDENCE ENTERED
23rd Oct 2018ASSIGNED TO LIE
11th Oct 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
15th Apr 2018NON-FINAL ACTION WRITTEN
15th Apr 2018NON-FINAL ACTION E-MAILED